- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04214847
The Outcome of Ahmed Glaucoma Valve in Difficult Glaucoma Cases
December 30, 2019 updated by: khaled hamdi elbaklish, Ain Shams University
One- Year Follow up of Two Models of Ahmed Glaucoma Valves (S2 and FP7) in Refractory Glaucoma
The clinical difference (mean IOP, success rate, and complications) on using S2 and FP7 models of Ahmed Glaucoma Valve that had similar dimensions and different materials used for their construction in one year follow up was evaluated.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Refractory glaucoma is a difficult subject; many glaucoma devices are tried to reduce IOP.
Glaucoma devices is now an integral part of glaucoma surgery.
AGV is commonly used.
The investigators need to compare the efficiency and failure rate of two models of AGV.
The point that is the biological reaction around capsule can affect the efficiency.
Study Type
Interventional
Enrollment (Actual)
1
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- primary glaucoma patients with repeated failed trabeculectomy or other intraocular surgery.
- patients had secondary glaucoma known to have a high failure rate with trabeculectomy such as neovascular, uveitis, post keratoplasty glaucoma or iridocorneal endothelial syndrome-associated glaucoma.
Exclusion Criteria:
- patients lacked light perception, unwilling or unable to give informed consent, lived out of the area and were expected to be unavailable for follow-up visits,
- patients had previous aqueous shunt implanted in the same eye, other external impediment to supero-temporal drainage device implantation.
- patients had silicone oil, vitreous in the anterior chamber sufficient to require a vitrectomy.
- patients had uveitis associated with a systemic condition like juvenile rheumatoid arthritis.
patients had nanophthalmos, Sturge-Weber syndrome or other conditions associated with elevated episcleral venous pressure.
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: polypropylene plate of Ahmed Glaucoma Valve
polypropylene plate of Ahmed Glaucoma Valve procedures were performed under local anesthesia except for children, general anesthesia was used.
The polypropylene plate was primed and placed in the superotemporal quadrant after making fornix-based conjunctival flap.
The valve plate was secured to sclera with 10-0 nylon sutures 10 mm posterior to the limbus.
Before implantation, applying sponges soaked with Mitomycin- c 0.3 cc for three minutes on bare sclera at this quadrant.
The tube was placed in the anterior chamber through a 23-gauge needle tract at the limbus.
The tube left patent and viscoelastic substance injected into anterior chamber.
A donor scleral graft was secured with interrupted 10-0 nylon sutures over the exposed portion of the tube.
Conjunctiva was sutured with 10-0 nylon sutures.
|
The surgical procedure was identical for both implant types and was performed as described previously.9,14
All surgical procedures were performed under local anesthesia except for children, general anesthesia was used.
The valve plate was primed and placed in the superotemporal quadrant after making fornix-based conjunctival flap.
The valve plate was secured to sclera with 10-0 nylon sutures 10 mm posterior to the limbus.
Before implantation, applying sponges soaked with Mitomycin- c 0.3 cc for three minutes on bare sclera at this quadrant.
The tube was placed in the anterior chamber through a 23-gauge needle tract at the limbus.
The tube left patent and viscoelastic substance injected into anterior chamber.
A donor scleral graft was secured with interrupted 10-0 nylon sutures over the exposed portion of the tube.
Conjunctiva was sutured with 10-0 nylon sutures.
|
Active Comparator: silicone plate of Ahmed Glaucoma Valve
silicone plate of Ahmed Glaucoma Valve procedures were performed under local anesthesia except for children, general anesthesia was used.
The silicone plate was primed and placed in the superotemporal quadrant after making fornix-based conjunctival flap.
The valve plate was secured to sclera with 10-0 nylon sutures 10 mm posterior to the limbus.
Before implantation, applying sponges soaked with Mitomycin- c 0.3 cc for three minutes on bare sclera at this quadrant.
The tube was placed in the anterior chamber through a 23-gauge needle tract at the limbus.
The tube left patent and viscoelastic substance injected into anterior chamber.
A donor scleral graft was secured with interrupted 10-0 nylon sutures over the exposed portion of the tube.
Conjunctiva was sutured with 10-0 nylon sutures.
|
The surgical procedure was identical for both implant types and was performed as described previously.9,14
All surgical procedures were performed under local anesthesia except for children, general anesthesia was used.
The valve plate was primed and placed in the superotemporal quadrant after making fornix-based conjunctival flap.
The valve plate was secured to sclera with 10-0 nylon sutures 10 mm posterior to the limbus.
Before implantation, applying sponges soaked with Mitomycin- c 0.3 cc for three minutes on bare sclera at this quadrant.
The tube was placed in the anterior chamber through a 23-gauge needle tract at the limbus.
The tube left patent and viscoelastic substance injected into anterior chamber.
A donor scleral graft was secured with interrupted 10-0 nylon sutures over the exposed portion of the tube.
Conjunctiva was sutured with 10-0 nylon sutures.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
the postoperative mean IOP in both groups compared with the baseline IOP baseline IOP .
Time Frame: one-year follow up
|
All measurements of the postoperative mean IOPs at 12 months were compared with the baseline IOP .
|
one-year follow up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2012
Primary Completion (Actual)
March 12, 2014
Study Completion (Actual)
July 15, 2014
Study Registration Dates
First Submitted
December 22, 2019
First Submitted That Met QC Criteria
December 30, 2019
First Posted (Actual)
January 2, 2020
Study Record Updates
Last Update Posted (Actual)
January 2, 2020
Last Update Submitted That Met QC Criteria
December 30, 2019
Last Verified
December 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FWA000017585 FMASU19/2017
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
in ophthalmology department-ophthalmic units-journal club
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glaucoma, Open-Angle
-
AllerganRecruiting18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) (ARGOS)Ocular Hypertension | Open-angle GlaucomaUnited States
-
Aerie PharmaceuticalsCompletedOcular Hypertension | Open-angle Glaucoma
-
West Virginia UniversityUniversity of Pittsburgh; University of MichiganWithdrawnOpen-angle Glaucoma
-
Glaukos CorporationUnknownOpen-Angle GlaucomaSpain, Germany, Austria, Turkey
-
Alcon ResearchWithdrawnOpen-Angle Glaucoma
-
Asociación para Evitar la Ceguera en MéxicoUnknown
-
Pharmaceutical Research NetworkCompleted
-
National Eye Institute (NEI)CompletedOpen-Angle Glaucoma
Clinical Trials on Ahmed Glaucoma Valve surgery
-
Menoufia UniversityMansoura UniversityCompleted
-
Peter Netland, MDNew World Medical, Inc.Completed
-
Ain Shams UniversityCompletedGlaucoma, Open-Angle | Glaucoma, Angle-Closure | Glaucoma, Neovascular | Glaucoma Secondary
-
Mansoura UniversityCompleted
-
Centre hospitalier de l'Université de Montréal...RecruitingGlaucoma | Corneal TransplantationCanada
-
SOLX, Inc.SuspendedGlaucoma | Glaucoma, Open AngleUnited States, Israel, Canada, India, Poland
-
Tissue Tech Inc.Columbia University; National Eye Institute (NEI); Bascom Palmer Eye Institute; The New York Eye & Ear InfirmaryCompleted
-
Federal University of São PauloUnknown
-
Technische Universität DresdenCompleted